Literature DB >> 18287025

JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.

Changlin Li1, Baoxue Ge, Matthew Nicotra, Joel N H Stern, Hernan D Kopcow, Xi Chen, Jack L Strominger.   

Abstract

Interaction of the activating receptor NKG2D with its ligands is a major stimulatory pathway for cytotoxicity of natural killer (NK) cells. Here, the signaling pathway involved after NKG2D ligation is examined. Either incubation of the NKG2D-bearing human NKL tumor cell line with K562 target cells or cross-linking with NKG2D mAb induced strong activation of the mitogen-activated protein (MAP) kinases. Selective inhibition of JNK MAP kinase with four different means of inhibition greatly reduced NKG2D-mediated cytotoxicity toward target cells and furthermore, blocked the movement of the microtubule organizing center (MTOC), granzyme B (a component of cytotoxic granules), and paxillin (a scaffold protein) to the immune synapse. NKG2D-induced activation of JNK kinase was also blocked by inhibitors of Src protein tyrosine kinases and phospholipase PLCgamma, upstream of JNK. Similarly, a second MAP kinase pathway through ERK was previously shown to be required for NK cell cytotoxicity. Thus, activation of two MAP kinase pathways is required for cytotoxic granule and MTOC polarization and for cytotoxicity of human NK cells when NKG2D is ligated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287025      PMCID: PMC2268577          DOI: 10.1073/pnas.0712310105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

Authors:  Leonidas N Carayannopoulos; Olga V Naidenko; Daved H Fremont; Wayne M Yokoyama
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.

Authors:  Simona Zompi; Jessica A Hamerman; Kouetsu Ogasawara; Edina Schweighoffer; Victor L J Tybulewicz; James P Di Santo; Lewis L Lanier; Francesco Colucci
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

3.  ULBP4 is a novel ligand for human NKG2D.

Authors:  N Jan Chalupny; Claire L Sutherland; William A Lawrence; Annie Rein-Weston; David Cosman
Journal:  Biochem Biophys Res Commun       Date:  2003-05-23       Impact factor: 3.575

Review 4.  Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses.

Authors:  Yatin M Vyas; Hina Maniar; Bo Dupont
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

5.  A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.

Authors:  Andreas Diefenbach; Jennifer K Hsia; Ming-Yu B Hsiung; David H Raulet
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

6.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Authors:  Susan Gilfillan; Emily L Ho; Marina Cella; Wayne M Yokoyama; Marco Colonna
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

7.  Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.

Authors:  Andreas Diefenbach; Elena Tomasello; Mathias Lucas; Amanda M Jamieson; Jennifer K Hsia; Eric Vivier; David H Raulet
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

8.  The specificities of protein kinase inhibitors: an update.

Authors:  Jenny Bain; Hilary McLauchlan; Matthew Elliott; Philip Cohen
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

9.  NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.

Authors:  Daniel D Billadeau; Jadee L Upshaw; Renee A Schoon; Christopher J Dick; Paul J Leibson
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

Review 10.  Human natural killer cell receptors and co-receptors.

Authors:  R Biassoni; C Cantoni; D Pende; S Sivori; S Parolini; M Vitale; C Bottino; A Moretta
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

View more
  40 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

Review 2.  IQGAP1: a regulator of intracellular spacetime relativity.

Authors:  Subramaniam Malarkannan; Aradhana Awasthi; Kamalakannan Rajasekaran; Pawan Kumar; Kristina M Schuldt; Allison Bartoszek; Niranjan Manoharan; Nicholas K Goldner; Colleen M Umhoefer; Monica S Thakar
Journal:  J Immunol       Date:  2012-03-01       Impact factor: 5.422

Review 3.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

4.  Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling.

Authors:  Ashley Mentlik James; Hsiang-Ting Hsu; Prachi Dongre; Gulbu Uzel; Emily M Mace; Pinaki P Banerjee; Jordan S Orange
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

5.  Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Authors:  Thomas W Miller; Sukhbir Kaur; Kelly Ivins-O'Keefe; David D Roberts
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

6.  Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.

Authors:  S Liu; H Zhang; M Li; D Hu; C Li; B Ge; B Jin; Z Fan
Journal:  Cell Death Differ       Date:  2012-11-16       Impact factor: 15.828

7.  RasGRP1 is required for human NK cell function.

Authors:  Suk Hyung Lee; Sohyun Yun; Jiwon Lee; Mi Jeong Kim; Zheng-Hao Piao; Mira Jeong; Jin Woong Chung; Tae-Don Kim; Suk Ran Yoon; Philip D Greenberg; Inpyo Choi
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion.

Authors:  Colin M Segovis; Renee A Schoon; Christopher J Dick; Lucas P Nacusi; Paul J Leibson; Daniel D Billadeau
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse.

Authors:  Misty R Jenkins; Andy Tsun; Jane C Stinchcombe; Gillian M Griffiths
Journal:  Immunity       Date:  2009-10-16       Impact factor: 43.474

10.  Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.

Authors:  Sunil K Joshi; Gillian A Lang; Jason L Larabee; T Scott Devera; Lindsay M Aye; Hemangi B Shah; Jimmy D Ballard; Mark L Lang
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.